Prevnar

Known as: Prevenar 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
INTRODUCTION BCG vaccination has been associated with beneficial non-specific effects on child health. Some immunological studies… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2016
2016
INTRODUCTION Acute otitis media (AOM) is common in children aged <3 years. A pneumococcal conjugate vaccine (PCV) (PCV7; Prevenar… (More)
Is this relevant?
2015
2015
BACKGROUND Detailed cost evaluations of delivery of new vaccines such as pneumococcal conjugate, human papillomavirus (HPV), and… (More)
Is this relevant?
2012
2012
BACKGROUND Bullous pemphigoid (BP) is a form of autoimmune bullous disease commonly seen in adults but rare amongst children… (More)
Is this relevant?
2010
2010
BACKGROUND Pneumococcal conjugate vaccine (PCV) was introduced in the United Kingdom immunization schedule in September 2006… (More)
Is this relevant?
2009
2009
We developed an age-structured, transmission-dynamic, mathematical model to quantify the direct and indirect benefits of infant… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2006
Review
2006
Safety of vaccines must be excellent to make vaccine's strategy acceptable, since it usually has a deferred individual benefit… (More)
Is this relevant?
2005
2005
AIMS Prospective study to evaluate the impact of the 7-valent pneumococcal conjugate vaccine (Prevenar) on the nasopharyngeal (NP… (More)
Is this relevant?
2005
2005
BACKGROUND The European Agency for the Evaluation of Medicinal Products (EMEA) granted market authorisation to the heptavalent… (More)
Is this relevant?
2003
2003
UNLABELLED Invasive pneumococcal disease is presently a leading cause of mortality due to bacterial infectious diseases in French… (More)
Is this relevant?